{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:47:48Z","timestamp":1791848868281,"version":"4.3.4"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,7,9]],"date-time":"2015-07-09T00:00:00Z","timestamp":1436400000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)","award":["308723\/2013-9"],"award-info":[{"award-number":["308723\/2013-9"]}]},{"name":"NENASC Project (PRONEX-FAPESC\/CNPq)","award":["1262\/2012-9"],"award-info":[{"award-number":["1262\/2012-9"]}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de Ensino Superior (CAPES)"},{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s12640-015-9540-1","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T09:51:20Z","timestamp":1436349080000},"page":"222-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Effects of Agmatine on Depressive-Like Behavior Induced by Intracerebroventricular Administration of 1-Methyl-4-phenylpyridinium (MPP+)"],"prefix":"10.1007","volume":"28","author":[{"given":"Morgana","family":"Moretti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian Binder","family":"Neis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filipe Carvalho","family":"Matheus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio Pe\u00f1a","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscila Batista","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille Mertins","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana L\u00facia S.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui Daniel","family":"Prediger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,9]]},"reference":[{"issue":"Suppl 11","key":"9540_CR1","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1002\/mds.20460","volume":"20","author":"CH Adler","year":"2005","unstructured":"Adler CH (2005) Nonmotor complications in Parkinson\u2019s disease. Mov Disord 20(Suppl 11):S23\u2013S29","journal-title":"Mov Disord"},{"key":"9540_CR2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/mds.23895","volume":"27","author":"B Ballanger","year":"2012","unstructured":"Ballanger B, Klinger H, Eche J, Lerond J, Vallet AE, Le Bars D, Tremblay L, Sgambato-Faure V, Broussolle E, Thobois S (2012) Role of serotonergic 1A receptor dysfunction in depression associated with Parkinson\u2019s disease. Mov Disord 27:84\u201389","journal-title":"Mov Disord"},{"key":"9540_CR3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.brainres.2014.09.068","volume":"1593","author":"TB Bassani","year":"2014","unstructured":"Bassani TB, Gradowski RW, Zaminelli T, Barbiero JK, Santiago RM, Boschen SL, da Cunha C, Lima MM, Andreatini R, Vital MA (2014) Neuroprotective and antidepressant-like effects of melatonin in a rotenone-induced Parkinson\u2019s disease model in rats. Brain Res 1593:95\u2013105","journal-title":"Brain Res"},{"key":"9540_CR4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bbr.2014.06.029","volume":"271","author":"K Berghauzen-Maciejewska","year":"2014","unstructured":"Berghauzen-Maciejewska K, Kuter K, Kolasiewicz W, Glowacka U, Dziubina A, Ossowska K, Wardas J (2014) Pramipexole but not imipramine or fluoxetine reverses the \u201cdepressive-like\u201d behaviour in a rat model of preclinical stages of Parkinson\u2019s disease. Behav Brain Res 271:343\u2013353","journal-title":"Behav Brain Res"},{"key":"9540_CR5","doi-asserted-by":"crossref","first-page":"e0117698","DOI":"10.1371\/journal.pone.0117698","volume":"10","author":"K Berghauzen-Maciejewska","year":"2015","unstructured":"Berghauzen-Maciejewska K, Wardas J, Kosmowska B, Glowacka U, Kuter K, Ossowska K (2015) Alterations of BDNF and trkB mRNA expression in the 6-hydroxydopamine-induced model of preclinical stages of Parkinson\u2019s disease: an influence of chronic pramipexole in rats. PLoS One 10:e0117698","journal-title":"PLoS One"},{"issue":"Suppl 2","key":"9540_CR6","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/S1353-8020(03)00022-1","volume":"9","author":"I Bodis-Wollner","year":"2003","unstructured":"Bodis-Wollner I (2003) Neuropsychological and perceptual defects in Parkinson\u2019s disease. Parkinsonism Relat Disord 9(Suppl 2):S83\u2013S89","journal-title":"Parkinsonism Relat Disord"},{"key":"9540_CR7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res 318:121\u2013134","journal-title":"Cell Tissue Res"},{"key":"9540_CR8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01245227","volume":"91","author":"AS Brown","year":"1993","unstructured":"Brown AS, Gershon S (1993) Dopamine and depression. J Neural Transm 91:75\u2013109","journal-title":"J Neural Transm"},{"key":"9540_CR9","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejphar.2007.08.010","volume":"575","author":"J Budni","year":"2007","unstructured":"Budni J, Gadotti VM, Kaster MP, Santos AR, Rodrigues AL (2007) Role of different types of potassium channels in the antidepressant-like effect of agmatine in the mouse forced swimming test. Eur J Pharmacol 575:87\u201393","journal-title":"Eur J Pharmacol"},{"key":"9540_CR10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainres.2013.03.029","volume":"1513","author":"AA Castro","year":"2013","unstructured":"Castro AA, Wiemes BP, Matheus FC, Lapa FR, Viola GG, Santos AR, Tasca CI, Prediger RD (2013) Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson\u2019s disease. Brain Res 1513:103\u2013116","journal-title":"Brain Res"},{"key":"9540_CR11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.expneurol.2014.09.016","volume":"263","author":"CC Chiu","year":"2015","unstructured":"Chiu CC, Yeh TH, Lai SC, Wu-Chou YH, Chen CH, Mochly-Rosen D, Huang YC, Chen YJ, Chen CL, Chang YM, Wang HL, Lu CS (2015) Neuroprotective effects of aldehyde dehydrogenase 2 activation in rotenone-induced cellular and animal models of parkinsonism. Exp Neurol 263:244\u2013253","journal-title":"Exp Neurol"},{"key":"9540_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2003.tb07458.x","volume":"991","author":"S Fahn","year":"2003","unstructured":"Fahn S (2003) Description of Parkinson\u2019s disease as a clinical syndrome. Ann NY Acad Sci 991:1\u201314","journal-title":"Ann NY Acad Sci"},{"key":"9540_CR13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jpsychires.2014.07.024","volume":"58","author":"AE Freitas","year":"2014","unstructured":"Freitas AE, Bettio LE, Neis VB, Moretti M, Ribeiro CM, Lopes MW, Leal RB, Rodrigues AL (2014a) Sub-chronic agmatine treatment modulates hippocampal neuroplasticity and cell survival signaling pathways in mice. J Psychiatr Res 58:137\u2013146","journal-title":"J Psychiatr Res"},{"key":"9540_CR14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.pnpbp.2013.12.012","volume":"50","author":"AE Freitas","year":"2014","unstructured":"Freitas AE, Bettio LE, Neis VB, Santos DB, Ribeiro CM, Rosa PB, Farina M, Rodrigues AL (2014b) Agmatine abolishes restraint stress-induced depressive-like behavior and hippocampal antioxidant imbalance in mice. Prog Neuropsychopharmacol Biol Psychiatry 50:143\u2013150","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"9540_CR15","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1007\/s12035-014-8827-1","volume":"51","author":"AE Freitas","year":"2014","unstructured":"Freitas AE, Egea J, Buendia I, Navarro E, Rada P, Cuadrado A, Rodrigues AL, Lopez MG (2014c) Agmatine induces Nrf2 and protects against corticosterone effects in hippocampal neuronal cell line. Mol Neurobiol 51(3):1504\u20131519","journal-title":"Mol Neurobiol"},{"key":"9540_CR16","author":"AE Freitas","year":"2015","unstructured":"Freitas AE, Egea J, Buendia I, Gomez-Rangel V, Parada E, Navarro E, Casas AI, Wojnicz A, Ortiz JA, Cuadrado A, Ruiz-Nuno A, Rodrigues AL, Lopez MG (2015) Agmatine, by improving neuroplasticity markers and inducing Nrf2, prevents corticosterone-induced depressive-like behavior in mice. Mol Neurobiol. doi: 10.1007\/s12035-015-9182-6","journal-title":"Mol Neurobiol"},{"key":"9540_CR17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0304-3940(00)01625-6","volume":"296","author":"GM Gilad","year":"2000","unstructured":"Gilad GM, Gilad VH (2000) Accelerated functional recovery and neuroprotection by agmatine after spinal cord ischemia in rats. Neurosci Lett 296:97\u2013100","journal-title":"Neurosci Lett"},{"key":"9540_CR18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s11064-005-6865-9","volume":"30","author":"GM Gilad","year":"2005","unstructured":"Gilad GM, Gilad VH, Finberg JP, Rabey JM (2005) Neurochemical evidence for agmatine modulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity. Neurochem Res 30:713\u2013719","journal-title":"Neurochem Res"},{"key":"9540_CR19","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1017\/S1461145713001119","volume":"17","author":"CN Haile","year":"2014","unstructured":"Haile CN, Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Foulkes A, Iqbal S, Mahoney JJ 3rd, De La Garza R 2nd, Charney DS, Newton TF, Mathew SJ (2014) Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression. Int J Neuropsychopharmacol 17:331\u2013336","journal-title":"Int J Neuropsychopharmacol"},{"key":"9540_CR20","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1476-5381.1957.tb01354.x","volume":"12","author":"TJ Haley","year":"1957","unstructured":"Haley TJ, McCormick WG (1957) Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother 12:12\u201315","journal-title":"Br J Pharmacol Chemother"},{"key":"9540_CR21","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1176\/ajp.151.7.1010","volume":"151","author":"P Hantz","year":"1994","unstructured":"Hantz P, Caradoc-Davies G, Caradoc-Davies T, Weatherall M, Dixon G (1994) Depression in Parkinson\u2019s disease. Am J Psychiatry 151:1010\u20131014","journal-title":"Am J Psychiatry"},{"key":"9540_CR22","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s12035-013-8466-y","volume":"48","author":"YY He","year":"2013","unstructured":"He YY, Zhang XY, Yung WH, Zhu JN, Wang JJ (2013) Role of BDNF in central motor structures and motor diseases. Mol Neurobiol 48:783\u2013793","journal-title":"Mol Neurobiol"},{"issue":"Suppl 1","key":"9540_CR23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-2007-1014317","volume":"27","author":"A Heinz","year":"1994","unstructured":"Heinz A, Schmidt LG, Reischies FM (1994) Anhedonia in schizophrenic, depressed, or alcohol-dependent patients\u2013neurobiological correlates. Pharmacopsychiatry 27(Suppl 1):7\u201310","journal-title":"Pharmacopsychiatry"},{"key":"9540_CR24","author":"J Hui","year":"2014","unstructured":"Hui J, Zhang J, Kim H, Tong C, Ying Q, Li Z, Mao X, Shi G, Yan J, Zhang Z, Xi G (2014) Fluoxetine regulates neurogenesis in vitro through modulation of GSK-3beta\/beta-catenin signaling. Int J Neuropsychopharmacol. doi: 10.1093\/ijnp\/pyu099","journal-title":"Int J Neuropsychopharmacol"},{"key":"9540_CR25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0197-0186(94)00122-B","volume":"26","author":"Y Itano","year":"1995","unstructured":"Itano Y, Kitamura Y, Nomura Y (1995) Biphasic effects of MPP+, a possible parkinsonism inducer, on dopamine content and tyrosine hydroxylase mRNA expression in PC12 cells. Neurochem Int 26:165\u2013171","journal-title":"Neurochem Int"},{"key":"9540_CR26","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","volume":"82","author":"JA Javitch","year":"1985","unstructured":"Javitch JA, D\u2019Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82:2173\u20132177","journal-title":"Proc Natl Acad Sci USA"},{"key":"9540_CR27","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.neuropharm.2009.01.015","volume":"56","author":"H Jourdi","year":"2009","unstructured":"Jourdi H, Hamo L, Oka T, Seegan A, Baudry M (2009) BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices. Neuropharmacology 56:876\u2013885","journal-title":"Neuropharmacology"},{"key":"9540_CR28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1046\/j.1440-1681.1999.03113.x","volume":"26","author":"K Kaku","year":"1999","unstructured":"Kaku K, Shikimi T, Kamisaki Y, Shinozuka K, Ishino H, Okunishi H, Takaori S (1999) Elevation of striatal interleukin-6 and serum corticosterone contents in MPTP-treated mice. Clin Exp Pharmacol Physiol 26:680\u2013683","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"9540_CR29","first-page":"780","volume":"27","author":"DJ Kim","year":"2006","unstructured":"Kim DJ, Kim DI, Lee SK, Suh SH, Lee YJ, Kim J, Chung TS, Lee JE (2006) Protective effect of agmatine on a reperfusion model after transient cerebral ischemia: temporal evolution on perfusion MR imaging and histopathologic findings. AJNR Am J Neuroradiol 27:780\u2013785","journal-title":"AJNR Am J Neuroradiol"},{"key":"9540_CR30","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jns.2014.03.028","volume":"340","author":"EA Kozina","year":"2014","unstructured":"Kozina EA, Khakimova GR, Khaindrava VG, Kucheryanu VG, Vorobyeva NE, Krasnov AN, Georgieva SG, Kerkerian-Le Goff L, Ugrumov MV (2014) Tyrosine hydroxylase expression and activity in nigrostriatal dopaminergic neurons of MPTP-treated mice at the presymptomatic and symptomatic stages of parkinsonism. J Neurol Sci 340:198\u2013207","journal-title":"J Neurol Sci"},{"key":"9540_CR31","first-page":"377","volume":"45","author":"GN Kryzhanovskii","year":"1995","unstructured":"Kryzhanovskii GN, Krupina NA, Kucherianu VG (1995) A new model of an experimental depressive syndrome in rats induced by the systemic administration to the animals of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Zh Vyssh Nerv Deiat Imeni I P Pavlova 45:377\u2013387","journal-title":"Zh Vyssh Nerv Deiat Imeni I P Pavlova"},{"key":"9540_CR32","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neulet.2014.12.030","volume":"589","author":"R Kumari","year":"2015","unstructured":"Kumari R, Kumar JB, Luthra PM (2015) Post-lesion administration of 7-NI attenuated motor and non-motor deficits in 6-OHDA induced bilaterally lesioned female rat model of Parkinson\u2019s disease. Neurosci Lett 589:191\u2013195","journal-title":"Neurosci Lett"},{"key":"9540_CR33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.brainres.2009.05.046","volume":"1281","author":"WT Lee","year":"2009","unstructured":"Lee WT, Hong S, Yoon SH, Kim JH, Park KA, Seong GJ, Lee JE (2009) Neuroprotective effects of agmatine on oxygen-glucose deprived primary-cultured astrocytes and nuclear translocation of nuclear factor-kappa B. Brain Res 1281:64\u201370","journal-title":"Brain Res"},{"key":"9540_CR34","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s13311-012-0165-2","volume":"10","author":"KW Lee","year":"2013","unstructured":"Lee KW, Im JY, Woo JM, Grosso H, Kim YS, Cristovao AC, Sonsalla PK, Schuster DS, Jalbut MM, Fernandez JR, Voronkov M, Junn E, Braithwaite SP, Stock JB, Mouradian MM (2013) Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson\u2019s disease. Neurotherapeutics 10:143\u2013153","journal-title":"Neurotherapeutics"},{"key":"9540_CR35","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/npp.2012.263","volume":"38","author":"FE Lotrich","year":"2013","unstructured":"Lotrich FE, Albusaysi S, Ferrell RE (2013) Brain-derived neurotrophic factor serum levels and genotype: association with depression during interferon-alpha treatment. Neuropsychopharmacology 38:985\u2013995","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"9540_CR36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.parkreldis.2015.03.024","volume":"21","author":"P Martinez-Martin","year":"2015","unstructured":"Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, Frades-Payo B, Aguera-Ortiz L, Weintraub D, Riesco A, Kurtis MM, Chaudhuri KR (2015) Neuropsychiatric symptoms and caregiver\u2019s burden in Parkinson\u2019s disease. Parkinsonism Relat Disord 21(6):629\u2013634","journal-title":"Parkinsonism Relat Disord"},{"key":"9540_CR37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bbr.2012.08.017","volume":"235","author":"FC Matheus","year":"2012","unstructured":"Matheus FC, Aguiar AS Jr, Castro AA, Villarinho JG, Ferreira J, Figueiredo CP, Walz R, Santos AR, Tasca CI, Prediger RD (2012) Neuroprotective effects of agmatine in mice infused with a single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Behav Brain Res 235:263\u2013272","journal-title":"Behav Brain Res"},{"key":"9540_CR38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.neuro.26.043002.094919","volume":"26","author":"R Mayeux","year":"2003","unstructured":"Mayeux R (2003) Epidemiology of neurodegeneration. Annu Rev Neurosci 26:81\u2013104","journal-title":"Annu Rev Neurosci"},{"key":"9540_CR39","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00702-010-0464-x","volume":"117","author":"EL Moreira","year":"2010","unstructured":"Moreira EL, Rial D, Aguiar AS Jr, Figueiredo CP, Siqueira JM, DalBo S, Horst H, de Oliveira J, Mancini G, dos Santos TS, Villarinho JG, Pinheiro FV, Marino-Neto J, Ferreira J, De Bem AF, Latini A, Pizzolatti MG, Ribeiro-do-Valle RM, Prediger RD (2010) Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson\u2019s disease. J Neural Transm 117:1337\u20131351","journal-title":"J Neural Transm"},{"key":"9540_CR40","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jpsychires.2011.11.009","volume":"46","author":"M Moretti","year":"2012","unstructured":"Moretti M, Colla A, de Oliveira BG, dos Santos DB, Budni J, de Freitas AE, Farina M, Severo Rodrigues AL (2012) Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress. J Psychiatr Res 46:331\u2013340","journal-title":"J Psychiatr Res"},{"key":"9540_CR41","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2741\/710","volume":"6","author":"M Moretti","year":"2014","unstructured":"Moretti M, Matheus FC, de Oliveira PA, Neis VB, Ben J, Walz R, Rodrigues AL, Prediger RD (2014) Role of agmatine in neurodegenerative diseases and epilepsy. Front Biosci 6:341\u2013359","journal-title":"Front Biosci"},{"issue":"3","key":"9540_CR42","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/jpi.12212","volume":"58","author":"A Naskar","year":"2015","unstructured":"Naskar A, Prabhakar V, Singh R, Dutta D, Mohanakumar KP (2015) Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice. J Pineal Res 58(3):262\u2013274","journal-title":"J Pineal Res"},{"key":"9540_CR43","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbr.2013.12.038","volume":"261","author":"VB Neis","year":"2014","unstructured":"Neis VB, Manosso LM, Moretti M, Freitas AE, Daufenbach J, Rodrigues AL (2014) Depressive-like behavior induced by tumor necrosis factor-alpha is abolished by agmatine administration. Behav Brain Res 261:336\u2013344","journal-title":"Behav Brain Res"},{"key":"9540_CR44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2014.12.009","volume":"130","author":"VB Neis","year":"2015","unstructured":"Neis VB, Moretti M, Manosso LM, Lopes MW, Leal RB, Rodrigues AL (2015) Agmatine enhances antidepressant potency of MK-801 and conventional antidepressants in mice. Pharmacol Biochem Behav 130:9\u201314","journal-title":"Pharmacol Biochem Behav"},{"key":"9540_CR45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1034\/j.1600-0447.2002.02229.x","volume":"106","author":"FM Nilsson","year":"2002","unstructured":"Nilsson FM, Kessing LV, Sorensen TM, Andersen PK, Bolwig TG (2002) Major depressive disorder in Parkinson\u2019s disease: a register-based study. Acta Psychiatr Scand 106:202\u2013211","journal-title":"Acta Psychiatr Scand"},{"key":"9540_CR46","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neuroscience.2014.07.046","volume":"277","author":"SP Patil","year":"2014","unstructured":"Patil SP, Jain PD, Ghumatkar PJ, Tambe R, Sathaye S (2014) Neuroprotective effect of metformin in MPTP-induced Parkinson\u2019s disease in mice. Neuroscience 277:747\u2013754","journal-title":"Neuroscience"},{"key":"9540_CR47","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","volume":"50","author":"W Paulus","year":"1991","unstructured":"Paulus W, Jellinger K (1991) The neuropathologic basis of different clinical subgroups of Parkinson\u2019s disease. J Neuropathol Exp Neurol 50:743\u2013755","journal-title":"J Neuropathol Exp Neurol"},{"key":"9540_CR48","volume-title":"The mouse brain in stereotaxic coordinates","author":"G Paxinos","year":"2004","unstructured":"Paxinos G, Franklin KBJ (2004) The mouse brain in stereotaxic coordinates. Elsevier Academic Press, Amsterdam, Boston"},{"key":"9540_CR49","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0003-2697(77)90043-4","volume":"83","author":"GL Peterson","year":"1977","unstructured":"Peterson GL (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem 83:346\u2013356","journal-title":"Anal Biochem"},{"key":"9540_CR50","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.bjp.0704153","volume":"133","author":"W Raasch","year":"2001","unstructured":"Raasch W, Schafer U, Chun J, Dominiak P (2001) Biological significance of agmatine, an endogenous ligand at imidazoline binding sites. Br J Pharmacol 133:755\u2013780","journal-title":"Br J Pharmacol"},{"key":"9540_CR51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-6147(00)01460-7","volume":"21","author":"DJ Reis","year":"2000","unstructured":"Reis DJ, Regunathan S (2000) Is agmatine a novel neurotransmitter in brain? Trends Pharmacol Sci 21:187\u2013193","journal-title":"Trends Pharmacol Sci"},{"key":"9540_CR52","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s12031-013-0074-9","volume":"51","author":"KR Rekha","year":"2013","unstructured":"Rekha KR, Selvakumar GP, Sethupathy S, Santha K, Sivakamasundari RI (2013) Geraniol ameliorates the motor behavior and neurotrophic factors inadequacy in MPTP-induced mice model of Parkinson\u2019s disease. J Mol Neurosci 51:851\u2013862","journal-title":"J Mol Neurosci"},{"key":"9540_CR53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuropharm.2015.01.030","volume":"93C","author":"Z Ren","year":"2015","unstructured":"Ren Z, Yang N, Ji C, Zheng J, Wang T, Liu Y, Zuo P (2015) Neuroprotective effects of 5-(4-hydroxy-3-dimethoxybenzylidene)-thiazolidinone in MPTP induced Parkinsonism model in mice. Neuropharmacology 93C:209\u2013218","journal-title":"Neuropharmacology"},{"key":"9540_CR54","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/JCP.0b013e3181fc2ec7","volume":"30","author":"V Ricci","year":"2010","unstructured":"Ricci V, Pomponi M, Martinotti G, Bentivoglio A, Loria G, Bernardini S, Caltagirone C, Bria P, Angelucci F (2010) Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients. J Clin Psychopharmacol 30:751\u2013753","journal-title":"J Clin Psychopharmacol"},{"key":"9540_CR55","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","volume":"34","author":"RM Santiago","year":"2010","unstructured":"Santiago RM, Barbieiro J, Lima MM, Dombrowski PA, Andreatini R, Vital MA (2010) Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson\u2019s disease are predominantly associated with serotonin and dopamine. Prog Neuropsychopharmacol Biol Psychiatry 34:1104\u20131114","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"9540_CR56","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neuropharm.2013.05.025","volume":"73","author":"S Sathiya","year":"2013","unstructured":"Sathiya S, Ranju V, Kalaivani P, Priya RJ, Sumathy H, Sunil AG, Babu CS (2013) Telmisartan attenuates MPTP induced dopaminergic degeneration and motor dysfunction through regulation of alpha-synuclein and neurotrophic factors (BDNF and GDNF) expression in C57BL\/6\u00a0J mice. Neuropharmacology 73:98\u2013110","journal-title":"Neuropharmacology"},{"key":"9540_CR57","doi-asserted-by":"crossref","first-page":"34451","DOI":"10.1074\/jbc.M202099200","volume":"277","author":"PA Serra","year":"2002","unstructured":"Serra PA, Sciola L, Delogu MR, Spano A, Monaco G, Miele E, Rocchitta G, Miele M, Migheli R, Desole MS (2002) The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induces apoptosis in mouse nigrostriatal glia. Relevance to nigral neuronal death and striatal neurochemical changes. J Biol Chem 277:34451\u201334461","journal-title":"J Biol Chem"},{"key":"9540_CR58","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jneuroim.2004.06.011","volume":"158","author":"YQ Shen","year":"2005","unstructured":"Shen YQ, Hebert G, Lin LY, Luo YL, Moze E, Li KS, Neveu PJ (2005) Interleukine-1beta and interleukine-6 levels in striatum and other brain structures after MPTP treatment: influence of behavioral lateralization. J Neuroimmunol 158:14\u201325","journal-title":"J Neuroimmunol"},{"key":"9540_CR59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1601-5215.2012.00675.x","volume":"25","author":"B Shopsin","year":"2013","unstructured":"Shopsin B (2013) The clinical antidepressant effect of exogenous agmatine is not reversed by parachlorophenylalanine: a pilot study. Acta Neuropsychiatr 25:113\u2013118","journal-title":"Acta Neuropsychiatr"},{"key":"9540_CR60","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/mds.1099","volume":"16","author":"LM Shulman","year":"2001","unstructured":"Shulman LM, Taback RL, Bean J, Weiner WJ (2001) Comorbidity of the nonmotor symptoms of Parkinson\u2019s disease. Mov Disord 16:507\u2013510","journal-title":"Mov Disord"},{"issue":"Suppl 2","key":"9540_CR61","first-page":"S65","volume":"64","author":"T Simuni","year":"2008","unstructured":"Simuni T, Sethi K (2008) Nonmotor manifestations of Parkinson\u2019s disease. Ann Neurol 64(Suppl 2):S65\u2013S80","journal-title":"Ann Neurol"},{"key":"9540_CR62","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1176\/jnp.13.2.187","volume":"13","author":"JR Slaughter","year":"2001","unstructured":"Slaughter JR, Slaughter KA, Nichols D, Holmes SE, Martens MP (2001) Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson\u2019s disease. J Neuropsychiatry Clin Neurosci 13:187\u2013196","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9540_CR63","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85:367\u2013370","journal-title":"Psychopharmacology"},{"key":"9540_CR64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2013.10.041","volume":"720","author":"BG Taksande","year":"2013","unstructured":"Taksande BG, Faldu DS, Dixit MP, Sakaria JN, Aglawe MM, Umekar MJ, Kotagale NR (2013) Agmatine attenuates chronic unpredictable mild stress induced behavioral alteration in mice. Eur J Pharmacol 720:115\u2013120","journal-title":"Eur J Pharmacol"},{"key":"9540_CR65","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.expneurol.2014.09.021","volume":"263","author":"YH Tsou","year":"2015","unstructured":"Tsou YH, Shih CT, Ching CH, Huang JY, Jen CJ, Yu L, Kuo YM, Wu FS, Chuang JI (2015) Treadmill exercise activates Nrf2 antioxidant system to protect the nigrostriatal dopaminergic neurons from MPP+ toxicity. Exp Neurol 263:50\u201362","journal-title":"Exp Neurol"},{"key":"9540_CR66","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.nbd.2008.07.015","volume":"32","author":"MG Vuckovic","year":"2008","unstructured":"Vuckovic MG, Wood RI, Holschneider DP, Abernathy A, Togasaki DM, Smith A, Petzinger GM, Jakowec MW (2008) Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. Neurobiol Dis 32:319\u2013327","journal-title":"Neurobiol Dis"},{"key":"9540_CR67","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.neuropharm.2007.03.017","volume":"52","author":"W Wang","year":"2007","unstructured":"Wang W, Yang Y, Ying C, Li W, Ruan H, Zhu X, You Y, Han Y, Chen R, Wang Y, Li M (2007) Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity. Neuropharmacology 52:1678\u20131684","journal-title":"Neuropharmacology"},{"key":"9540_CR68","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.euroneuro.2007.04.001","volume":"17","author":"XL Wei","year":"2007","unstructured":"Wei XL, Su RB, Wu N, Lu XQ, Zheng JQ, Li J (2007) Agmatine inhibits morphine-induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in rats. Eur Neuropsychopharmacol 17:790\u2013799","journal-title":"Eur Neuropsychopharmacol"},{"key":"9540_CR69","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000087097","volume":"52","author":"P Willner","year":"2005","unstructured":"Willner P (2005) Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 52:90\u2013110","journal-title":"Neuropsychobiology"},{"key":"9540_CR70","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s10072-008-0986-2","volume":"29","author":"H Yokoyama","year":"2008","unstructured":"Yokoyama H, Kuroiwa H, Yano R, Araki T (2008) Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson\u2019s disease. Neurol Sci 29:293\u2013301","journal-title":"Neurol Sci"},{"key":"9540_CR71","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/mds.10698","volume":"19","author":"M Zach","year":"2004","unstructured":"Zach M, Friedman A, Slawek J, Derejko M (2004) Quality of life in POLISH patients with long-lasting Parkinson\u2019s disease. Mov Disord 19:667\u2013672","journal-title":"Mov Disord"},{"key":"9540_CR72","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2007.03.027","volume":"565","author":"MP Zeidan","year":"2007","unstructured":"Zeidan MP, Zomkowski AD, Rosa AO, Rodrigues AL, Gabilan NH (2007) Evidence for imidazoline receptors involvement in the agmatine antidepressant-like effect in the forced swimming test. Eur J Pharmacol 565:125\u2013131","journal-title":"Eur J Pharmacol"},{"key":"9540_CR73","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00001756-200203250-00005","volume":"13","author":"AD Zomkowski","year":"2002","unstructured":"Zomkowski AD, Hammes L, Lin J, Calixto JB, Santos AR, Rodrigues AL (2002) Agmatine produces antidepressant-like effects in two models of depression in mice. NeuroReport 13:387\u2013391","journal-title":"NeuroReport"},{"key":"9540_CR74","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.brainres.2004.07.041","volume":"1023","author":"AD Zomkowski","year":"2004","unstructured":"Zomkowski AD, Oscar Rosa A, Lin J, Santos AR, Calixto JB, Rodrigues AL (2004) Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain Res 1023:253\u2013263","journal-title":"Brain Res"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-015-9540-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-015-9540-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-015-9540-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T13:31:29Z","timestamp":1559482289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-015-9540-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,9]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["9540"],"URL":"https:\/\/doi.org\/10.1007\/s12640-015-9540-1","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"value":"1029-8428","type":"print"},{"value":"1476-3524","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,9]]}}}